Nuvectis Pharma logo

Nuvectis Pharma

NVCT | NASDAQ
Chart Builder DCF Calculator
$19.11
-$1.13 (-5.58%)
At close: Nov 16, 2026, 4:00 PM ET
$19.11
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-5.58%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
29.5
Fundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #817/1021 (Top 80%)

Key Statistics

Market Data

Market Cap $657.17M
1D Range
18.64 20.00
52W Range
5.81 28.53

Valuation (TTM)

PE -10.11
PB 5.19
EV/EBITDA -9.84

Valuation (NTM)

Forward PE N/A
Forward PEG -0.20
Price Target $39.00
Loading financial charts...

Profile

Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative...

Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Feb 4, 2022
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$39.00
Upside
+104.08%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.